ITRN vs RZLV

ITRN exhibits exceptional financial health with a Piotroski F-Score of 8/9, indicating strong operational efficiency and balance sheet strength. While the current price of $53.54 is a significant premium over the Graham Number ($26.84), it remains well below the growth-based intrinsic value of $67.31. The company combines steady double-digit growth with a highly attractive 11.21% dividend yield and negligible debt (D/E 0.02). Despite a bearish technical trend score and weak insider sentiment, the fundamental data suggests a high-quality compounder with significant margin of safety in its health metrics.

RZLV exhibits critical financial instability, highlighted by a weak Piotroski F-Score of 2/9 and a Current Ratio of 0.67, indicating significant liquidity risk. While the company shows astronomical YoY revenue growth of 4888.40% and strong gross margins (65.98%), these are offset by a devastating profit margin of -216.69% and an extreme Price/Sales ratio of 23.01. The stark divergence between the 'Strong Buy' analyst consensus ($10.75 target) and the bearish technical trend (0/100) suggests a highly speculative asset trading on future AI promises rather than current fundamental health.